BCL2 and diffuse large B-cell lymphoma: However, given the extensive systemic involvement and pathology findings in this case, the diagnosis was favored to be systemic DLBCL/HGBL-MYC/BCL2 with cutaneous manifestations, rather than primary cutaneous DLBCL, leg type with extracutaneous manifestations.4